search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | September 30, 2020

Topical PDE4 Inhibitor from Arcutis Shows Benefit in Seborrheic Dermatitis

Positive topline data from a Phase 2 clinical trial suggest ARQ-154 (topical roflumilast foam) from Arcutis Biotherapeutics, Inc. is a potential treatment for seborrheic dermatitis. Study results show that...

Read More

News | September 30, 2020

Clearasil Steps Up to End Bullying, Support Skin Positivity

Clearasil is donating $25,000 to STOMP Out Bullying for National Bullying Prevention Month. As part of the partnership, Clearasil is also using its national platform to further the reach and impact of STOMP Out Bullying's...

Read More

News | September 30, 2020

Industry Responds to COVID-19: BTL Gives Back

BTL is revamping several of their manufacturing facilities to provide face masks and ventilators to the medical community.   As of September 2020, BTL's European manufacturing facilities have been...

Read More

News | September 29, 2020

Forte Biosciences, Inc. Announces First Patient Dosed in Study of FB-401 for the Treatment of Children and Adults With AD

The first patient has been dosed in Forte Biosciences, Inc.’s clinical trial of FB-401 for the treatment of atopic dermatitis (AD). The multi-center, placebo controlled clinical trial of FB-401 is expected to enroll approximately...

Read More

News | September 28, 2020

Marketing Exec Lizette Williams Joins RealSelf’s Board

Marketing and advertising executive Lizette Williams is the newest member of RealSelf’s Board of Directors. Ms. Williams serves as the Global Head of Vertical Solutions Marketing at Facebook. Prior to Facebook she has worked...

Read More

Advertisement

The Latest News

Advertisement

View more